Non-neonatal hypoglycemia (peds) - Revision history

Danbot: Add peer-reviewed reference

2026-03-22T10:16:16Z

Add peer-reviewed reference

← Older revision		Revision as of 10:16, 22 March 2026
Line 12:		Line 12:

	==Clinical Features==		==Clinical Features==
	*Most common features:		*Most common features: <ref>Thornton PS, et al. Recommendations from the Pediatric Endocrine Society for Evaluation and Management of Persistent Hypoglycemia in Neonates, Infants, and Children. J Pediatr. 2015;167(2):238-245. PMID 25957977</ref>
	**[[nausea and vomiting (peds)\|Vomiting]]		**[[nausea and vomiting (peds)\|Vomiting]]
	**[[altered mental status (peds)\|Altered mental status]]		**[[altered mental status (peds)\|Altered mental status]]

2019-10-06T19:08:19Z

References

2019-09-28T16:47:53Z

@@ Line 4: / Line 4: @@
 *Inadequate oral intake
 *Excess insulin
-**Newborns of diabetic mothers
+**Newborns of [[DM|diabetic mothers]]
-*Deficient hyperglycemic hormones (GH or adrenal hormone deficiency)
+*Deficient hyperglycemic hormones (growth or [[CAH|adrenal hormone deficiency]])
-*Fatty acid oxidation or carbohydrate metabolism disorders
+*[[Inborn errors of metabolism]]: fatty acid oxidation or carbohydrate metabolism disorders
 *Prematurity (inadequate glycogen stores)
-*Sepsis
+*[[Sepsis (peds)|Sepsis]]
-*Etoh exposure (children have low glycogen stores)
+*[[ETOH]] exposure (children have low glycogen stores)
 ==Clinical Features==
-*Most common features: vomiting, altered mental status, poor feeding
+*Most common features:
-**May also see lethargy, apnea, seizure
+**[[nausea and vomiting (peds)|Vomiting]]
 ==Differential Diagnosis==
-*Ingestions (e.g. ETOH)
+====Systemic Illness====
-*Metabolic disease^
+*Critical Illness
-*[[Sepsis (peds)|Sepsis]]
+**[[Sepsis (peds)|Sepsis]]
 ==Evaluation==

2019-03-15T16:17:02Z

← Older revision		Revision as of 16:17, 15 March 2019
Line 1:		Line 1:
	''This page is for <u>non-neonatal pediatric</u> hypoglycemia. See [[hypoglycemia]] for adult patients or [[neonatal hypoglycemia ~~(peds)~~]].''		''This page is for <u>non-neonatal pediatric</u> hypoglycemia. See [[hypoglycemia]] for adult patients or [[neonatal hypoglycemia]].''
	==Background==		==Background==
	===Etiology===		===Etiology===

2019-03-15T16:16:38Z

← Older revision		Revision as of 16:16, 15 March 2019
Line 1:		Line 1:
			''This page is for <u>non-neonatal pediatric</u> hypoglycemia. See [[hypoglycemia]] for adult patients or [[neonatal hypoglycemia (peds)]].''
	==Background==		==Background==
	===Etiology===		===Etiology===

2019-03-15T16:12:48Z

← Older revision	Revision as of 16:12, 15 March 2019
(No difference)

2019-03-15T16:10:59Z

Evaluation

← Older revision		Revision as of 16:10, 15 March 2019
Line 20:		Line 20:

	==Evaluation==		==Evaluation==
	*Blood glucose <45 in symptomatic neonate
	*Blood glucose <35 in asymptomatic neonate

	===Work-Up===		===Work-Up===
	*Blood glucose level		*Blood glucose level
Line 28:		Line 25:
	**If ketones: adrenal or GH deficiency, inborn errors of metabolism		**If ketones: adrenal or GH deficiency, inborn errors of metabolism
	**If no ketones: Hyperinsulinemia, fatty acid oxidation defects		**If no ketones: Hyperinsulinemia, fatty acid oxidation defects

			===Diagnosis===
			*Blood glucose <45 in symptomatic neonate
			*Blood glucose <35 in asymptomatic neonate

	==Management==		==Management==

2016-10-02T20:09:24Z

Text replacement - "*UA" to "*Urinalysis"

← Older revision		Revision as of 20:09, 2 October 2016
Line 25:		Line 25:
	===Work-Up===		===Work-Up===
	*Blood glucose level		*Blood glucose level
	*UA		*[[Urinalysis]]
	**If ketones: adrenal or GH deficiency, inborn errors of metabolism		**If ketones: adrenal or GH deficiency, inborn errors of metabolism
	**If no ketones: Hyperinsulinemia, fatty acid oxidation defects		**If no ketones: Hyperinsulinemia, fatty acid oxidation defects

2016-08-30T14:09:27Z

Text replacement - "@" to "at"

← Older revision		Revision as of 14:09, 30 August 2016
Line 32:		Line 32:
	''See [[critical care quick reference]] for doses by weight		''See [[critical care quick reference]] for doses by weight
	*Glucose		*Glucose
	**Bolus [[D10W]] 2mL/kg; then infuse D10W @ 0.06-0.08mL/kg/min		**Bolus [[D10W]] 2mL/kg; then infuse D10W at 0.06-0.08mL/kg/min
	*[[Glucagon]]		*[[Glucagon]]
	**Used for persistent hypoglycemia despite glucose administration		**Used for persistent hypoglycemia despite glucose administration

2016-07-30T14:13:58Z

Text replacement - "AMS" to "altered mental status"

← Older revision		Revision as of 14:13, 30 July 2016
Line 11:		Line 11:

	==Clinical Features==		==Clinical Features==
	*Most common features: vomiting, ~~AMS~~, poor feeding		*Most common features: vomiting, altered mental status, poor feeding
	**May also see lethargy, apnea, seizure		**May also see lethargy, apnea, seizure